Literature DB >> 8964905

Multiple sclerosis: the proinflammatory cytokines lymphotoxin-alpha and tumour necrosis factor-alpha are upregulated in cerebrospinal fluid mononuclear cells.

D Matusevicius1, V Navikas, M Söderström, B G Xiao, M Haglund, S Fredrikson, H Link.   

Abstract

Lymphotoxin-alpha (LT-alpha) and tumour necrosis factor-alpha (TNF-alpha) promote inflammation in autoimmune diseases and have been detected in the multiple sclerosis (MS) brain lesions and blood, suggesting these cytokines are also present in the cerebrospinal fluid (CSF). To study this, mononuclear cells (MNC) were examined for transcripts of LT-alpha and TNF-alpha, using in situ hybridization (ISH) with synthetic oligonucleotide probes. Most patients with MS had LT-alpha and TNF-alpha mRNA-expressing MNC in their CSF at mean frequencies of about 1/2800 cells for both cytokines. Numbers were dramatically higher than in the paired blood specimens. Control patients with other inflammatory neurological diseases (OIND) also had LT-alpha and TNF-alpha mRNA-expressing cells in CSF but at mean frequencies of only 1/36,000 and 1/18,000 cells, respectively. In blood, levels were similar in OIND and MS. To elucidate the influence of myelin antigen stimulation on LT-alpha and TNF-alpha expression, MNC were cultivated with or without myelin basic protein. Strongly elevated levels of MBP-reactive TNF-alpha mRNA-expressing cells were detected in the MS patients' CSF, in particular when examined during clinical exacerbations, as well as MBP-reactive LT-alpha mRNA-expressing MNC. No such patterns were observed in the OIND controls. The strong accumulation of LT-alpha- and TNF-alpha-producing cells and of MBP-reactive LT-alpha and TNF-alpha mRNA-positive cells in the immediate vicinity of the demyelinating process in MS patients implicates a role of these cytokines in the development of MS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8964905     DOI: 10.1016/0165-5728(96)00032-x

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  16 in total

Review 1.  The role of TNFalpha and lymphotoxin in demyelinating disease.

Authors:  C Lock; J Oksenberg; L Steinman
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  Neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment.

Authors:  Gaylia Jean Harry; Andrew D Kraft
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-10       Impact factor: 4.481

3.  Stress and multiple sclerosis: what's new?

Authors:  Julián Benito-León
Journal:  Neuroepidemiology       Date:  2011-02-17       Impact factor: 3.282

4.  Transgenic expression of viral capsid proteins predisposes to axonal injury in a murine model of multiple sclerosis.

Authors:  Aleksandar Denic; Laurie Zoecklein; Jason Kerkvliet; Louisa Papke; Ramakrishna Edukulla; Arthur Warrington; Allan Bieber; Larry R Pease; Chella S David; Moses Rodriguez
Journal:  Brain Pathol       Date:  2011-02-11       Impact factor: 6.508

5.  Progressive decline in fractional anisotropy on serial DTI examinations of the corpus callosum: a putative marker of disease activity and progression in SPMS.

Authors:  Wei Tian; Tong Zhu; Jianhui Zhong; Xiang Liu; Praveen Rao; Benjamin M Segal; Sven Ekholm
Journal:  Neuroradiology       Date:  2011-05-13       Impact factor: 2.804

Review 6.  The signaling and apoptotic effects of TNF-related apoptosis-inducing ligand in HIV-1 associated dementia.

Authors:  Y Huang; N Erdmann; J Zhao; J Zheng
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

7.  Inhibition of Drp1 hyper-activation is protective in animal models of experimental multiple sclerosis.

Authors:  Fucheng Luo; Karl Herrup; Xin Qi; Yan Yang
Journal:  Exp Neurol       Date:  2017-02-24       Impact factor: 5.330

8.  Induction of lymphotoxin-alpha by interleukin-12 p40 homodimer, the so-called biologically inactive molecule, but not IL-12 p70.

Authors:  Malabendu Jana; Kalipada Pahan
Journal:  Immunology       Date:  2008-11-14       Impact factor: 7.397

9.  Exosomes from HIV-1-infected Cells Stimulate Production of Pro-inflammatory Cytokines through Trans-activating Response (TAR) RNA.

Authors:  Gavin C Sampey; Mohammed Saifuddin; Angela Schwab; Robert Barclay; Shreya Punya; Myung-Chul Chung; Ramin M Hakami; Mohammad Asad Zadeh; Benjamin Lepene; Zachary A Klase; Nazira El-Hage; Mary Young; Sergey Iordanskiy; Fatah Kashanchi
Journal:  J Biol Chem       Date:  2015-11-09       Impact factor: 5.157

10.  The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic Inflammation.

Authors:  Fabian Richter; Sarah K Williams; Katharina John; Carina Huber; Camille Vaslin; Henri Zanker; Richard Fairless; Kira Pichi; Silke Marhenke; Arndt Vogel; Marie-Ann Dhaen; Stefanie Herrmann; Andreas Herrmann; Klaus Pfizenmaier; Heike Bantel; Ricarda Diem; Roland E Kontermann; Roman Fischer
Journal:  Front Immunol       Date:  2021-07-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.